Skip to main content

Table 3 Clinical effectiveness

From: Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcoma

Characteristics Data
ORR 41.20%
DCR 70.60%
M-PFS (months) 6 (95%CI: 2–9)
6 months PFS rate 64.71%
  1. Data are presented as percentages or means
  2. Abbreviations: ORR The objective response rate, DCR The disease control rate, m-PFS The median progression-free survival